These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
139 related items for PubMed ID: 1925251
1. Active specific immunotherapy and immunochemotherapy in the treatment of lung and colon cancer. Hollinshead A. Semin Surg Oncol; 1991; 7(4):199-210. PubMed ID: 1925251 [Abstract] [Full Text] [Related]
2. Immunotherapy of cancer: current status. Goodnight JE, Morton DL. Prog Exp Tumor Res; 1980; 25():61-88. PubMed ID: 6986637 [No Abstract] [Full Text] [Related]
3. Adjuvant specific active lung cancer immunotherapy trials. Tumor-associated antigens. Hollinshead A, Stewart TH, Takita H, Dalbow M, Concannon J. Cancer; 1987 Sep 15; 60(6):1249-62. PubMed ID: 2441838 [Abstract] [Full Text] [Related]
4. Specific active immunotherapy with butanol-extracted, tumor-associated antigens incorporated into liposomes. Steele G, Ravikumar T, Ross D, King V, Wilson RE, Dodson T. Surgery; 1984 Aug 15; 96(2):352-9. PubMed ID: 6463864 [Abstract] [Full Text] [Related]
5. Specific active lung cancer immunotherapy. Immune correlates of clinical responses and an update of immunotherapy trials evaluations. Hollinshead A, Takita H, Stewart T, Raman S. Cancer; 1988 Oct 15; 62(8):1662-71. PubMed ID: 3048633 [Abstract] [Full Text] [Related]
6. [Reevaluation of immunopotentiation therapy for cancer]. Toyoshima K. Gan To Kagaku Ryoho; 2000 Jun 15; 27(6):817-23. PubMed ID: 10897207 [Abstract] [Full Text] [Related]
8. Preoperative mobilization of circulating dendritic cells by Flt3 ligand administration to patients with metastatic colon cancer. Morse MA, Nair S, Fernandez-Casal M, Deng Y, St Peter M, Williams R, Hobeika A, Mosca P, Clay T, Cumming RI, Fisher E, Clavien P, Proia AD, Niedzwiecki D, Caron D, Lyerly HK. J Clin Oncol; 2000 Dec 01; 18(23):3883-93. PubMed ID: 11099317 [Abstract] [Full Text] [Related]
9. Active specific immunotherapy for stage II and stage III human colon cancer: a randomised trial. Vermorken JB, Claessen AM, van Tinteren H, Gall HE, Ezinga R, Meijer S, Scheper RJ, Meijer CJ, Bloemena E, Ransom JH, Hanna MG, Pinedo HM. Lancet; 1999 Jan 30; 353(9150):345-50. PubMed ID: 9950438 [Abstract] [Full Text] [Related]
10. A new approach in the immunotherapy of carcinoma of the colon and rectum. Wallack MK. J Surg Oncol; 1980 Jan 30; 13(1):29-34. PubMed ID: 7351837 [Abstract] [Full Text] [Related]
13. Active specific immunotherapy potential for the treatment of large bowel cancer. Kahan BD, Pellis NR, Rutzky LP, Wiseman F, Tom BH. Cancer; 1977 Nov 30; 40(5 Suppl):2740-6. PubMed ID: 922711 [Abstract] [Full Text] [Related]